
Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

